Consensus Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 09:53:34 2024-10-04 am EDT			5-day change	1st Jan Change
97.40 ^CHF	-0.07%		-0.75%	+14.53%

Oct. 02	NOVARTIS AG : Goldman Sachs reiterates its Neutral rating	ZD
Sep. 27	ETF of the week: Value ready to bounce back?

Evolution of the Average Target: Novartis AG

Evolution of the Target Price: Novartis AG

Changes in Analyst Recommendations: Novartis AG

99bad53d146af6d7760bc6.NT7o0nIHJbbkCVEvwKQsyf1eFzhh5jnlI9u-qGzIn8s.YAaMg0NfUeWcayZbkfUV-c0pRQ4C1VGfc5b05SSD7uYCUKmdPTQV469hMg~57e0ad78ff62acfb91bf7663be23df26

Analysts' recommendations: Novartis AG

NOVARTIS AG : Goldman Sachs reiterates its Neutral rating	Oct. 02	ZD
NOVARTIS AG : Goldman Sachs reiterates its Neutral rating	Sep. 18	ZD
NOVARTIS AG : Gets a Buy rating from UBS	Sep. 11	ZD
NOVARTIS : Goldman Sachs no longer Buy	Sep. 05	CF
Goldman Sachs Downgrades Novartis to Neutral From Buy, Adjusts Price Target to $121 From $119	Sep. 05	MT
Novartis shares fall back as Morgan Stanley takes a break	Sep. 05	CF
Goldman Sachs Downgrades Novartis to Neutral, Trims PT	Sep. 05	MT
NOVARTIS AG : Goldman Sachs is Neutral	Sep. 05	ZD
NOVARTIS : Jefferies upgrades to 'hold', share price consolidates	Sep. 03	CF
Jefferies Downgrades Novartis to Hold, Lowers PT	Sep. 03	MT
Jefferies Downgrades Novartis to Hold From Buy	Sep. 03	MT
NOVARTIS AG : From a Buy to Neutral rating by Jefferies	Sep. 03	ZD
NOVARTIS : Stifel confirms its recommendation on the stock	Aug. 08	CF
Novartis: downgrade by Stifel weighs on share price	Aug. 02	CF
Stifel Downgrades Novartis to Hold Rating, Lifts PT	Aug. 02	MT
NOVARTIS : Onboarding healthy earnings momentum	Aug. 01
DA Davidson Raises Price Target on Novartis to $120 From $110, Maintains Buy/Add Rating	Jul. 23	MT
Berenberg Raises Price Target on Novartis to CHF86 From CHF77, Maintains Hold Rating	Jul. 23	MT
NOVARTIS AG : Berenberg gives a Neutral rating	Jul. 23	ZD
Deutsche Bank Downgrades Novartis to Hold, Lifts PT	Jul. 19	MT
NOVARTIS AG : JP Morgan remains Neutral	Jul. 19	ZD
NOVARTIS : UBS raises its price target	Jul. 19	CF
NOVARTIS AG : DZ Bank maintains a Buy rating	Jul. 19	ZD
NOVARTIS AG : Deutsche Bank is now Neutral	Jul. 19	ZD
NOVARTIS AG : Goldman Sachs reaffirms its Buy rating	Jul. 19	ZD

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	NOVARTIS AG					+2.61%
	ELI LILLY AND COMPANY					+12.41%
	NOVO NORDISK A/S					+20.97%
	JOHNSON & JOHNSON					+6.88%
	ABBVIE INC.					+0.80%
	MERCK & CO., INC.					+26.18%
	ROCHE HOLDING AG					+15.66%
	ASTRAZENECA PLC					+18.19%
	AMGEN INC.					+2.54%
	PFIZER, INC.					+18.43%
	Average					+12.47%
	Weighted average by Cap.					+12.80%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

114.19USD

Average target price

117.18USD

Spread / Average Target

+2.61%

High Price Target

134.70USD

Spread / Highest target

+17.96%

Low Price Target

100.88USD

Spread / Lowest Target

-11.66%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

GOLDMAN SACHS	James Quigley
UBS	Matthew Weston
Jefferies & Co.
JEFFERIES	Peter Welford
alphavalue	Abhishek Raval
BERENBERG	Kerry Holford
Deutsche Bank Securities
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
DZ BANK	Elmar Kraus
JPMORGAN	Richard Vosser
BERNSTEIN RESEARCH	Florent Cespedes
BARCLAYS	Emily Field
Baader Bank
Berenberg Bank
BMO Capital
Kepler Capital Markets
Societe Generale
Redburn
Stifel Nicolaus
BNP Paribas
MORGAN STANLEY	Mark Purcell
Barrington Research
Credit Suisse
International Strategy & Investment Group
Morningstar
ODDO BHF
DA Davidson
Zacks Equity Research
Bank of America Securities/Merrill Lynch
Kepler Cheuvreux
Wolfe Research
AltaCorp Capital
DEUTSCHE BANK	Emmanuel Papadakis
HSBC
Exane BNP Paribas
Bryan, Garnier & Co.
Moody's Investors Service
Dundee
Exane BNP
Bernstein
Argus
Cowen
BRYAN GARNIER	Eric Le Berrigaud
LIBERUM CAPITAL	Graham Doyle
BANK OF AMERICA (BOFA)	Graham Parry